Muscle glutamine may protect the heart by supporting glutathione-dependent lipid peroxide removal
An early-fasting mimetic may protect the heart by using muscle glutamine to make glutathione. The claim would be challenged if restoring energy supply alone restored protection, or if blocking lipid damage failed to restore function while glutamine oxidation remained low.
Stage of verification
- Hypothesis published2026-10-06
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
The biological function description is being prepared
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Metabolism and energy
Lipid peroxidation
A process involving peroxide-chain propagation that can cause persistent cellular injury
Where this hypothesis actsHeart tissue during delayed feeding under an early-fasting mimetic
Hypotheses on this target 6
Inhibition4
Activation
Function preservation
Supplementation
Feedback restoration
Direct measurement
What is proposed
Suppress lipid oxidation locally
HowCombine an early-fasting signal with local suppression of lipid chain oxidation; test liproxstatin-1 in a cell model
Possible result
Possible preservation of cardiac protection with less demand for muscle glutamine
From the recordНовый вариант миметика мог бы сочетать ранний сигнал голодания с локальным подавлением цепного окисления липидов, снижая потребность в мышечном глутамине.
Metabolite or ion
Glutathione
An intracellular molecule used by glutathione peroxidase 4 to detoxify lipid peroxides
Where this hypothesis actsA cell model of cardiac protection with reduced glutamine oxidation
Hypotheses on this target 1- Supplementation1
Accelerated excretion
Composition restoration
What is proposed
Supplementation
Restore intracellular glutathione
With whatNot stated in the record
HowNot stated in the record
Possible result
Possible recovery of mimetic protection despite persistently reduced glutamine oxidation
From the recordподтверждённое восстановление внутриклеточного глутатиона возвращает защиту миметика при сохраняющемся снижении окисления глутамина.
Enzyme
GLS1
An enzyme that uses glutamine and can compete with its use in the hexosamine pathway
Where this hypothesis actsHeart tissue under an early-fasting mimetic
Hypotheses on this target 5- Inhibition4
- Activation
Lower level
Higher level
Replacement
Protection from degradation
Cofactor removal
Synthesis suppression- Function preservation
What is proposed
Inhibition
Suppress GLS1 to test the dependence of protection on glutamine metabolism
With whatNot stated in the record
HowNot stated in the record
Possible result
Expected rise in lipid peroxides before ATP falls
From the recordПосле подавления сердечной GLS1 липидные перекиси растут раньше падения АТФ.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
A treatment that imitates the first stages of going without food might protect the heart while drawing on supplies from muscle. The unexpected move is to propose that the borrowed material mainly helps prevent damage to heart-cell membranes, with preservation of energy following from preservation of the cells. This is a hypothesis generated by the pipeline, not a measured result.
- An intervention imitating early fasting is proposed to make heart protection depend on glutamine supplied by muscle.
- Heart-cell GLS1 converts incoming glutamine to glutamate.
- Glutamate supplies a building block for glutathione production.
- Glutathione supports removal of lipid peroxides by glutathione peroxidase 4.
- Reduced membrane damage preserves heart-cell function, with ATP preservation following cell preservation.
- Local suppression of spreading membrane fat oxidation is proposed to replace part of this protective dependency and reduce demand for muscle glutamine.
- Less lasting heart damage together with preserved muscle function is proposed to contribute to longer life.
A workshop may borrow supplies from a neighbouring store to keep its walls intact rather than to run its machines. Keeping the machines powered would not save the workshop if its walls were still falling apart.
Where the picture breaks: Glutamine can serve several purposes in the same cell, including energy production. The picture separates those purposes more cleanly than the proposed biology does and cannot establish which one accounts for protection.
- Master questionstep 01 of 04
Treatments that reproduce useful effects of normal bodily processes are proposed as possible ways to extend life.
Rests on: The goal is to identify processes worth reproducing, interventions that could reproduce them, and reasons those effects might extend life.
Stated in the chain - Goal pillarstep 02 of 04
An imitation of a bodily signal should match both the resources available to carry out the response and the body's actual need for it.
Rests on: The goal seeks useful effects from reproducing bodily processes; this stage introduces resource availability and need as conditions for usefulness.
AssumptionThe stage takes as given that matching the signal to available resources and actual need is a condition for benefit. The master question does not establish that condition.
- Gap questionstep 03 of 04
A fasting mimetic, an intervention that imitates a response to going without food, might preserve energy in a target tissue by consuming glutamine supplied by muscle. The proposed dependency is that interrupting this supply during delayed feeding would remove protection.
Rests on: The previous stage makes resource availability relevant to the effects of an imitated signal.
LeapThe previous stage does not identify early fasting, muscle glutamine, or transfer between tissues as the relevant signal and resource relationship. The supplied sources do not establish this particular dependency.
- Hypothesisstep 04 of 04
Muscle glutamine is proposed to protect the heart by supplying glutathione, a molecule cells use in protective chemical reactions. Glutaminase 1, abbreviated GLS1, converts glutamine to glutamate, a building block for glutathione. Glutathione peroxidase 4, an enzyme that uses glutathione to remove damaging oxidized membrane fats called lipid peroxides, is proposed to provide the decisive protection. On this account, maintaining adenosine triphosphate, abbreviated ATP, the cell's usable energy carrier, follows from keeping cells intact. Locally blocking the spread of membrane fat oxidation is proposed to reduce the heart's dependence on muscle glutamine.
Rests on: The preceding question supplies the proposed dependency between muscle glutamine and tissue protection. The endpoint offers membrane protection as an explanation for that dependency and for the apparent preservation of energy.
Stated in the chain
What is carried, and what is not. The abstract of S2, published in Advances in Experimental Medicine and Biology in 1998, describes glutamine as involved in maintaining the balance between usable and spent glutathione in heart and muscle; it does not establish muscle-to-heart transfer or the proposed protective sequence. No supplied source establishes the chain end to end, and S6, published in Antioxidants in 2022, reports the opposite direction for one key intervention: reducing GLS1 protected H9c2 cardioblasts, laboratory heart precursor cells, early in RSL3-induced ferroptosis, an experimentally triggered form of cell death involving membrane fat oxidation; that result does not establish what happens under an early-fasting mimetic or delayed feeding.S2S6
Where the reasoning is carried by something unstated · 2
- Goal pillar. The stage takes as given that matching the signal to available resources and actual need is a condition for benefit. The master question does not establish that condition.
- Gap question. The previous stage does not identify early fasting, muscle glutamine, or transfer between tissues as the relevant signal and resource relationship. The supplied sources do not establish this particular dependency. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Rescue by liproxstatin-1, a compound used here to inhibit cell death associated with membrane fat oxidation, could be mistaken for proof that muscle glutamine normally protects through glutathione. A downstream rescue can identify a preventable source of injury without identifying the original supply route. What closes it: The specified test requires restored cell function alongside confirmed low glutamine use for energy, rather than only a lower damage marker. Establishing the muscle-to-heart route additionally requires tracing glutamine from muscle into heart glutathione; adding labelled glutamine directly to cultured cells would not establish that origin.
- A rise in lipid peroxides before a fall in ATP could be read as proof that membrane damage is the primary cause of energy failure. The amount of ATP present and the rate at which cells produce or use it are different quantities, so timing alone does not separate this hypothesis from the rival involving controlled energy expenditure. What closes it: ATP amount, energy production and use, membrane damage, and cell function must be followed together. The proposed alternative-fuel comparison must verify restored energy production, and the prediction involving partial suppression of glutamine synthetase, abbreviated GLUL, the enzyme that makes glutamine from glutamate, requires confirmation that its activity was actually reduced.
- Failure of glutathione restoration to rescue function could be taken as a rejection of the hypothesis even if glutathione was not restored inside the cells. Conversely, protection after GLS1 suppression could be interpreted without acknowledging that the supplied literature already reports that direction in a different injury setting.S6 What closes it: The proposed rescue requires verified intracellular glutathione restoration and a defined functional outcome. GLS1 suppression must also be verified, with injury conditions and observation times fixed in advance; the opposing result in S6 makes the experimental setting a necessary part of interpreting the direction of the effect.
What would make this wrong. The central claim would fail if, under the proposed fasting-mimetic conditions, confirmed suppression of GLS1 removed protection, verified restoration of intracellular glutathione or suppression of membrane fat oxidation failed to restore function, and alternative fuel restored function by restoring energy production. That outcome would contradict the claim that membrane protection is the decisive dependency and that preserved ATP follows from it.
What it would change. If the proposed dependency held, reproducing an early-fasting response would require accounting for the muscle material spent on protecting heart membranes. It would support testing a combined intervention that reproduces the fasting signal while suppressing local membrane fat oxidation, with reduced muscle demand as a separate outcome to establish. A successful cell-level rescue would still not establish muscle-to-heart supply, preservation of whole-heart or muscle function during delayed feeding, or longer life.
Sources read · 8
Minerals, trace elements and related biological variables in athletes and during physical activity. · Clinica chimica acta; international journal of clinical chemistry · 2001
“Selenium in glutathione peroxidase protects the cardiovascular system and the muscles, and helps combat allergic and inflammatory diseases.”
Does not settle: The source does not establish that muscle glutamine supplies cardiac glutathione, that GLS1-derived glutamate supports GPX4-mediated lipid peroxide removal, that preventing membrane lipid peroxidation preserves ATP or cardiac function, or that a fasting mimetic affects these processes, muscle function, or lifespan.
Amino acid transport during muscle contraction and its relevance to exercise. · Advances in experimental medicine and biology · 1998
“Glutamine appears to be involved in the regulation of a number of important metabolic processes in heart and skeletal muscle (e.g., regulation of the glutathione reduced/oxidised ratio and regulation of protein and glycogen synthesis).”
Does not settle: Источник не устанавливает перенос мышечного глутамина в сердце, участие GLS1 или глутатионпероксидазы 4, удаление липидных перекисей, предотвращение повреждения мембран, сохранение АТФ, эффект задержки питания или миметика голодания, а также влияние на продолжительность жизни и мышечную функцию.
Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. · Annals of surgery · 1995
“The authors examined the effects of oral glutamine on tumor and host glutathione metabolism and response to methotrexate.”
Does not settle: Открытыми остаются защита сердца, использование мышечного глутамина, роль GLS1 и GPX4, удаление липидных перекисей, сохранение АТФ, условия голодания или задержки питания, действие миметика и влияние на продолжительность жизни.
Chronically and acutely exercised rats: biomarkers of oxidative stress and endogenous antioxidants. · Journal of applied physiology (Bethesda, Md. : 1985) · 2000
“Various biomarkers of oxidative stress were measured, namely, lipid peroxidation [malondialdehyde (MDA)], protein oxidation (protein carbonyl levels and glutamine synthetase activity), oxidative DNA damage (8-hydroxy-2'-deoxyguanosine), and endogenous antioxidants”
Does not settle: The abstract does not establish that muscle glutamine supplies cardiac glutathione, that GLS1-derived glutamate supports GPX4-mediated lipid peroxide removal, or that an early-fasting mimetic protects cardiac function through this pathway. It also does not test feeding delay, alternative respiratory substrates, local inhibition of lipid chain oxidation, ATP preservation, muscle-function preservation, or lifespan.
Integrative pharmacology reveals the mechanisms of Erzhi Pill, a traditional Chinese formulation, against diabetic cardiomyopathy. · Journal of ethnopharmacology · 2022
“In addition, 1H-NMR metabolomics confirmed that EZP primarily regulated both energy metabolism and amino acid metabolism, including the tricarboxylic acid (TCA) cycle, ketone bodies metabolism, glutamine and glutamate metabolism, glycine metabolism, and purine metabolism.”
Does not settle: Источник не исследует миметик голодания, использование мышечного глутамина сердцем, GLS1, синтез глутатиона, глутатионпероксидазу 4, липидные перекиси, сохранение АТФ, задержку питания, продолжительность жизни или свойство SPV_3. Он также не устанавливает причинную связь между обменом глутамина и защитой кардиомиоцитов.
Effects of Ferroptosis on the Metabolome in Cardiac Cells: The Role of Glutaminolysis. · Antioxidants (Basel, Switzerland) · 2022
“Genetic silencing of GLS1, which encodes the K-type mitochondrial glutaminase (glutaminase C), protected against ferroptosis in the early stage.”
Does not settle: The source does not establish effects of an early-fasting mimetic, muscle-derived glutamine, delayed feeding, alternative respiratory substrates, ATP preservation, whole-heart function, organismal longevity, or reduced dependence on muscle glutamine. Its GLS1 result is limited to the early stage of RSL3-induced ferroptosis in H9c2 cardioblasts.
Kaempferol protects against streptozotocin-induced diabetic cardiomyopathy in rats by a hypoglycemic effect and upregulating SIRT1. · Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2021
“On the other hand, overproduction of ROS is a major hallmark during the development of DC and other DM-induced complications and is the major pathophysiological mechanism underlying all other adverse effects including inflammation, fibrosis, and apoptosis (10, 51).”
Does not settle: The source does not establish protection by an early-fasting mimetic, muscle glutamine use, GLS1-derived glutamate, GPX4-dependent lipid peroxide removal, preservation of ATP as a downstream effect, loss of protection during delayed feeding, reduced glutamine dependence through local suppression of lipid oxidation, effects on lifespan, or SPV_3.
Effects of antioxidant system on coronary artery lesions in patients with abnormal glucose metabolism. · Aging clinical and experimental research · 2017
“Decreased plasma levels of CAT, SOD, GSH, GR, and GSH-Px were inversely correlated, at least to some extent, with the extent of coronary artery lesions.”
Does not settle: The source does not establish effects of fasting mimetics, muscle glutamine, GLS1-derived glutamate, GPX4-mediated lipid peroxide removal, membrane protection, ATP preservation, delayed feeding, alternative respiratory substrates, localized inhibition of lipid oxidation, muscle function, or lifespan.
The gap this hypothesis explains
Does copying early fasting preserve tissue energy using muscle fuel, with protection during delayed feeding requiring this transfer?
Original wording · exactly as the pipeline generated it
Может ли миметик раннего голодания сохранять энергию целевой ткани ценой расходования мышечного глутамина, и устраняет ли разрыв этого обмена защитный эффект при задержке питания?
What this question is asking
The question concerns whether a treatment that imitates the body's early response to going without food protects one tissue by drawing on fuel supplied by muscle. That fuel is glutamine, an amino acid that muscles produce and release and that other tissues can use. It asks whether the treatment preserves energy in the receiving tissue while feeding is delayed, compared with the same conditions without treatment. It then asks whether blocking the proposed glutamine transfer removes that protection compared with leaving the transfer intact. The treatment, receiving tissue, duration of the feeding delay and measures of energy and protection are unspecified; the proposed exchange is a possibility being questioned, rather than an established fact.
- Early fasting
- The initial period of going without food. The question gives no duration or specific bodily response that defines this period.
- Fasting mimetic
- A treatment intended to imitate some response to going without food. This names a proposed kind of intervention, not a specified substance or a demonstrated reproduction of every effect of fasting.
- Glutamine
- An amino acid, one of the substances used to make proteins, that also has other roles in the body. Here it is the proposed muscle-supplied fuel; S1 describes both its fuel role and its role in supporting production of genetic-information molecules.
- Skeletal muscle
- Muscle used to move and support the body. In this question it is the proposed source of glutamine supplied to another tissue.
- Receiving tissue
- The part of the body proposed to benefit from muscle-supplied glutamine. The question does not identify it, so the gut and kidney findings cannot automatically stand for the intended tissue.
- Tissue energy preservation
- Maintaining a tissue's available energy or ability to meet its energy needs. The question does not specify how this would be measured, and repair alone is not a stated measurement of it.
- Glutamine transfer
- The proposed passage of glutamine from muscle to a receiving tissue for use there. Increased release from muscle establishes only part of that proposed connection.
- Delayed feeding
- Food or nutritional supply arriving later than it otherwise would. Neither the length of the delay nor the feeding conditions are supplied.
- Protection
- A reduction in tissue harm or preservation of tissue function. The question does not define the outcome that would count as protection or establish that it is identical to maintaining energy.
- Ketone bodies
- A class of molecules the body can use as fuel during fasting. S2 examines elevated concentrations in relation to amino acid release from muscles of fasted birds.
- Alanine and glutamate
- Two amino acids involved in the muscle response described by S2. That source reports a shift away from alanine release and attributes increased glutamine production to greater glutamate availability.
- Glucocorticoids
- A class of hormones involved in responses to stress and regulation of how the body uses its resources. S3 describes them promoting protein breakdown, which increases muscle glutamine release.
- Protein breakdown
- The dismantling of proteins into smaller components, including amino acids. S3 places this process between the hormone response and increased glutamine supply for gut repair.
- Gut lining and immune cells
- The gut lining is the layer of cells facing the inside of the digestive tract; immune cells participate in the body's defenses. These are reported recipients or users of glutamine in S1 and S3.
- Dexamethasone
- A drug in the glucocorticoid class. S4 includes treatment with it among the settings associated with increased muscle glutamine release in sheep; the supplied material does not establish it as the fasting mimetic asked about.
- Energy is preserved, and blocking transfer removes protection Under this outcome, the treatment's benefit would depend on the muscle-to-tissue glutamine transfer under the conditions examined. Protection during delayed feeding would therefore require continued access to that supply, although a harmful cost to muscle would remain a separate question.
- Energy is preserved, but protection survives blocked transfer If the transfer were successfully blocked and protection remained, that transfer would not be necessary for the observed protection. Muscle glutamine release could accompany the treatment without explaining why the receiving tissue remains protected.
- The treatment does not preserve tissue energy The proposed energy benefit would not occur under the conditions examined. Even if muscle released more glutamine, that release would not establish the protective exchange described in the question.
Muscle-produced glutamine can supply fuel to cells lining internal surfaces and to immune cells, providing a reported starting point for the proposed connection between tissues [S1]. If a treatment preserves another tissue's energy by increasing its use of this supply, that benefit could depend on a continuing contribution from muscle. Increased glutamine release alone, however, would not establish either a damaging cost to muscle or protection of the receiving tissue. Mistaking release for demonstrated protection would overstate the evidence, while assuming protection is independent of muscle supply could conceal the dependency the question asks about.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Миметик раннего голодания сохраняет функцию сердца благодаря использованию мышечного глутамина для синтеза глутатиона. Полученный через GLS1 глутамат поддерживает обезвреживание липидных перекисей глутатионпероксидазой 4. Основная причинная зависимость защиты связана с предотвращением перекисного повреждения мембран; сохранение АТФ следует за сохранением клетки. При задержке питания разрыв обмена устраняет защиту, даже если другие субстраты поддерживают дыхание. Новый вариант миметика мог бы сочетать ранний сигнал голодания с локальным подавлением цепного окисления липидов, снижая потребность в мышечном глутамине. Предполагаемый вклад в продолжительность жизни связан со снижением остаточного повреждения при сохранении мышечной функции. Стабилизируемое свойство: SPV_3.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
После подавления сердечной GLS1 липидные перекиси растут раньше падения АТФ. В клеточной модели липроксстатин-1 либо подтверждённое восстановление внутриклеточного глутатиона возвращает защиту миметика при сохраняющемся снижении окисления глутамина. Альтернативное топливо, восстановившее энергетический поток, сохраняет недостаточную защиту. После обхода окислительного повреждения частичное подавление GLUL не должно воспроизводить обязательную потерю защиты, предсказанную IH_02.
Would tell it apart from at least one rival. The prediction specifies measurable temporal ordering and conditional protection outcomes. No rival prediction is supplied; the reference to IH_02 alone cannot support a comparison. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Доступны изотопное измерение включения глутамина в глутатион, липидомика окисленных фосфолипидов и клеточные пробы с ингибиторами ферроптоза. Одного снижения общего окислительного маркера недостаточно: требуется восстановление функции при подтверждённо низком глутаминовом окислении.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
После подавления сердечной GLS1 липидные перекиси растут раньше падения АТФ. В клеточной модели липроксстатин-1 либо подтверждённое восстановление внутриклеточного глутатиона возвращает защиту миметика при сохраняющемся снижении окисления глутамина. Альтернативное топливо, восстановившее энергетический поток, сохраняет недостаточную защиту. После обхода окислительного повреждения частичное подавление GLUL не должно воспроизводить обязательную потерю защиты, предсказанную another hypothesis of the same gap.
- What would separate them
Early-fasting mimetics may protect the heart by burning glutamine supplied by muscle predicts: У старых мышей при задержке питания миметик увеличивает чистый выход глутамина из задней конечности и его углеродный вклад в окислительный обмен сердца. Избирательное подавление сердечной GLS1 снижает образование АТФ раньше появления повреждений и устраняет защиту. В изолированном сердце альтернативное окисляемое топливо восстанавливает защиту при сохранённой блокаде GLS1, если экспериментально подтверждено восстановление энергетического потока. При повторных циклах величина мышечной потери связана с интегральным экспортом и недостаточным восстановительным синтезом.
- Rival 02 of 04What would separate them
Energy spending in the glutamine–glutamate cycle may protect the heart during fasting mimicry predicts: При неизменном поступлении глутамина и сохранённой GLS1 частичное подавление GLUL в кардиомиоцитах уменьшает встречные потоки синтеза и гидролиза глутамина, повышает отношение АТФ к аденозиндифосфату, но увеличивает восстановленность дыхательной цепи и устраняет защиту миметика. В клеточной модели регулируемая дополнительная АТФазная нагрузка восстанавливает защиту при сопоставимых аммиаке, глутатионе и гликозилировании. Простое энергетическое восполнение при отсутствии такого оборота защиты не возвращает.
- Rival 03 of 04What would separate them
Connected mitochondria may protect ageing heart cells when muscle glutamine supply falls predicts: При сопоставимых массе митохондрий, максимальной дыхательной мощности и доступности топлива зависимость функции сердца от ослабления GLS1 имеет порог, положение которого меняется при изменении связности сети. Увеличение связности сохраняет защиту после ослабления GLS1 при низком поступлении мышечного глутамина. Фрагментация отменяет этот эффект даже при восстановленных глутатионе и гексозаминовом обмене. Порог должен воспроизводиться при двух независимых способах изменения связности.
- Rival 04 of 04What would separate them
Muscle glutamine may protect the heart by supplying nitrogen for protein glycosylation predicts: Миметик увеличивает включение амидного 15N глутамина в гексозамины целевой ткани. Частичное подавление GFAT1 устраняет защиту при сохранённых АТФ и глутатионе. N-ацетилглюкозамин восстанавливает защиту и уменьшает потребность в поступающем глутамине только при работоспособном пути его повторного использования. Частичное подавление GLS1 сохраняет или усиливает защиту при доступном альтернативном топливе. Блокада использования N-ацетилглюкозамина отменяет специфическое восстановление.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.